Intravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations

Table 6

Hb >12 g/dL and end of treatment (Day 56) from clinical Study 7 (ITT population).

	1500 mg IV iron ()	1000 mg IV iron ()	value
(%) patients with Hb >12.0 g/dL	265 (24.4%)	169 (15.6%)

Hb = hemoglobin; ITT = intent-to-treat.
Data on file, Luitpold Pharmaceuticals, Inc.